Jun 02, 2020 EBMT to track long-term outcome data for Yescarta®, a CAR T therapy for adults living with two types of aggressive non-Hodgkin lymphoma
Apr 30, 2020 My paper of the month - Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma.
